MicroRNAs function as either tumor suppressor or oncogene in human cancers. This study aimed to explore the role of miR-27b in osteosarcoma. Expression of miR-27b or homeobox B8 in osteosarcoma cell lines was analyzed by quantitative real-time polymerase chain reaction and Western blot, respectively. Luciferase activity reporter assay and Western blot were conducted to explore the association between miR-27b and homeobox B8. Cell Counting Kit-8, colony formation assay, and wound-healing assay were performed to investigate the role of miR-27b or homeobox B8 on cell proliferation, colony formation, and cell migration. Expression of miR-27b was significantly reduced, while homeobox B8 was increased in osteosarcoma cell lines. In addition, homeobox B8 was validated as a direct target of homeobox B8. Moreover, miR-27b regulates osteosarcoma cell proliferation, colony formation, and migration through targeting homeobox B8. Taken together, our study provides novel insight into the progression of osteosarcoma, and the miR-27b-homeobox B8 axis identified may be developed as therapeutic targets against hepatocellular carcinoma in the future.
Introduction
Osteosarcoma (OS) frequently occurs in children and adolescent and is the most common bone tumor with the molecular mechanisms underlying OS progression largely unknown. 1 The past decades have identified a whole bunch of abnormally expressed molecules or mechanistic changes in OS. 2, 3 Therefore, further investigations on these molecules will help to develop novel targeted therapy for OS.
MicroRNAs (miRNAs) are highly conserved RNAs that lack protein-coding potential but are capable to regulate approximately one-third of human gene expression through 3 0 -untranslated region (3 0 -UTR) binding. 4 Over 2000 miRNAs have been identified in humans and were reported to play crucial roles in human diseases, particularly in cancer. 5 miR-27b has been found to exert dual roles in human cancers. For example, miR-27b was revealed to be a tumor suppressive RNA in cancers including hepatocellular carcinoma, colorectal cancer, and gastric cancer. [6] [7] [8] On the contrary, it was found to function as an oncogenic RNA in cancers including cervical cancer and glioma. 9, 10 However, there is no report concerning the biological role of miR-27b in OS till now.
Homeobox B8 (HOXB8), a member of HOX family, was abnormally expressed in several human cancers. 11 It was found that the knockdown of expression of HOXB8 inhibits colorectal cancer cell proliferation, migration, and invasion but promotes cell apoptosis through Wnt/b-catenin signaling pathway. 12 Besides that, HOXB8 expression was revealed to be higher in metastatic gastric cancer tissues than in 1 Orthopaedic Eight Disease Area, Mindong Hospital, Ningde, People's Republic of China 2 Mindong Hospital, Ningde, People's Republic of China nonmetastatic tissues. 13 In the meantime, HOXB8 overexpression promotes gastric cancer cells migration, invasion, and epithelial-mesenchymal transformation, while HOXB8 knockdown has opposite effects. 13 In addition, HOXB8 expression was found could be regulated by noncoding RNAs. Liu et al found HOXB8 could be regulated by miR-32-3p to affect cervical cancer metastasis. 14 Shen et al identified miR-196 was also an upstream regulator for HOXB8 in colorectal cancer to affect cancer cell response to chemotherapy. 15 Therefore, in this study, we analyzed miR-27b in OS cell lines. The effects of miR-27b on OS cell proliferation, colony formation, and migration, as well as HOXB8 expression, were investigated. This study will be helpful to further clarify the role of miR-27b in OS development.
Materials and Methods

Cell Lines and Cell Culture
Human OS cell lines (Saos2, MG63, and HOS) and normal osteoblasts (hFOB 1.19) obtained at American Type Culture Collection (ATCC, Manassas, Virginia) were incubated at RPMI-1640 medium (Invitrogen, Thermo Fisher Scientific, Inc, Waltham, Massachusetts) with 10% fetal bovine serum, 1% penicillin/streptomycin, and maintained at a 37 C humidified incubator containing 5% of CO 2 .
Data Collection
The data set GSE65071 containing miRNA expression data from 15 healthy control tissues and 20 tumor tissues was downloaded from Gene Expression Omnibus (https://www.ncbi.nlm. nih.gov/geo/query/acc.cgi? acc¼GSE65071). Expression level of miR-27b in tumor or control tissues was then analyzed using this data set.
Cell Transfection
To manipulate miR-27b expression in OS cell lines, synthetic miR27b mimic (5 0 -AGAGCUUAGCUGAUUGGUGAAC-3 0 ) and the corresponding negative control (NC-miR, 5
0 -GATAGGCG-TACTGAGTACTTGA-3 0 ) purchased from GenePharm (Shanghai, China) were utilized. To control the expression of HOXB8, the pcDNA3.1 containing open reading frame of HOXB8 (pHOXB8) and the empty vector pcDNA3.1 purchased at GenScript (Nanjing, Jiangsu, China) were used. Cells transfection was conducted using Lipofectamine 2000 (Invitrogen) when cells cultured to approximately 70% to 80% of confluence.
Cell Counting Kit-8 Assay
Cells (3 Â 10 3 cells/well) were seeded in 96-well plates and incubated for 0, 1, 2, or 3 days. Then, Cell Counting Kit-8 Assay (CCK-8) solution (10 mL) was added to the plate at the abovementioned time and further incubated for 2 hours. Optical density was measured at 450 nm using microplate reader (Bio-Rad, Hercules, California).
Colony Formation Assay
Quantitative Real-time Polymerase Chain Reaction Total RNA was extracted by Trizol reagent (Beyotime, Haimen, Jiangsu, China). Complementary DNA was transcribed from extracted RNA with miRNA Reverse Transcription Kit (Promega, Madison, Wisconsin). Quantitative real-time polymerase chain reaction (qRT-PCR) was performed in ABI 7500 system (Applied Biosystems, Foster City, California) using SYBR Green Mix (Takara, Dalian, China). The primers for miR-27b are:
0 (reverse); and U6 small nuclear RNA (U6 snRNA) are:
0 -TATGGAACGCTTCACGAATTTGC-3 0 (reverse). The expression of miR-27b was normalized in U6 snRNA and analyzed with 2
ÀDDCt method. The following thermocycling conditions were used: 10 minutes at 95 C; 40 cycles of 1 minute at 95 C; 2 minutes at 63 C; and 1 minute at 72 C.
Western Blot
Proteins were extracted using Radio Immunoprecipitation Assay (RIPA) lysis buffer (Beyotime), resolved on 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis, and transferred to polyvinylidene difluoride membrane. Membranes were incubated with antibody against HOXB8 (ab125727; Abcam, Cambridge, Massachusetts) or glyceraldehyde-3-phosphate dehydrogenase (GAPDH, ab181602; Abcam) for overnight at 4 C after blocking with fat-free milk. Then, the membranes were incubated with horseradish peroxidase-conjugated secondary goat antirabbit secondary antibody (ab6721; Abcam). Band was developed using BeyoECL kit (Beyotime) and then analyzed with Image J version 1.42 software (NI, Bethesda, Maryland).
Dual Luciferase Activity Assay
TargetScan (http://www.targetscan.org/) algorithm was utilized to predict the targets of miR-27b. The wild-type HOXB8 3 0 -UTR cloned into pmir-GLO (Promega) was named as wt-HOXB8, and mutant HOXB8 3 0 -UTR was named as mt-HOXB8. The luciferase reporter plasmid was transfected into cells in the presence of miR-27b mimic or NC-miR. After 48 hours of transfection, the cells were harvested to detect luciferase activity using dual luciferase reporter assay system (Promega).
Statistical Analysis
Data were presented as mean + standard deviation from 3 independent experiments after analysis with SPSS version 19.0 software (Chicago, Illinois). Student t test was employed to analyze differences between the 2 groups. Analysis of variance and Tukey post hoc test were utilized to analyze differences among 3 or more groups. P values < .05 were considered statistically significant.
Results
MicroRNA-27b Was Downregulated While HOXB8 Was Upregulated in OS
Expression level of miR-27b in OS cell lines and the hFOB 1.19 was analyzed by qRT-PCR. We found miR-27b expression was low in OS cell lines relative to hFOB 1.19 cell line ( Figure 1A) . Moreover, we analyzed miR-27b expression in OS tissues using data set GSE65071. We found miR-27b expression was significantly reduced in OS tissues compared to the normal tissues ( Figure 1B) . On the contrary, we found HOXB8 was highly expressed in OS cell lines compared to the hFOB 1.19 cell line ( Figure 1C) . The HOS and MG63 cell lines that have the first and second lowest miR-27b expression but highest HOXB8 expression, respectively, was selected for following experiments.
Overexpression of miR-27b Inhibits OS Cell Growth and Invasion
To assess the biological role of miR-27b in OS, we upregulated miR-27b expression in HOS and MG63 cell lines by miR-27b mimic. The qRT-PCR confirmed successful introduction of miR-27b mimic in HOS and MG63 cell lines (Figure 2A ). Cell Counting Kit-8 assay showed that introduction of miR-27b mimic reduced OS cell proliferation compared to NC-miR ( Figure 2B ). Colony formation assay indicated that overexpression of miR-27b decreased OS colony formation ability ( Figure 2C ). Wound-healing assay showed miR-27b mimic transfection induced OS cell migration inhibition ( Figure 2D ). The abovementioned results indicated that overexpression of miR-27b exerted tumor suppressive role in OS.
Homeobox B8 was a Direct Target of miR-27b
The binding region between miR-27b and the 3 0 -UTR of HOXB8 is shown in Figure 3A . Luciferase activity reporter assay revealed that relative luciferase activity in OS cell lines transfected with wt-HOXB8 was inhibited by miR-27b mimic ( Figure 3B ). Expression level of HOXB8 was found to be downregulated by miR-27b mimic ( Figure 3C ). These results indicate HOXB8 was a direct target of miR-27b.
MicroRNA-27b Regulates OS Progression Through Targeting HOXB8
To analyze the role of HOXB8 in miR-27b-induced suppression on OS cell growth and invasion, rescue experiments were conducted. Figure 4A showed that pHOXB8 transfection significantly increased the levels of HOXB8 in OS cell lines. Figure 4B to D showed the pHOXB8 significantly reversed the miR-27b mimic transfection-induced OS cell proliferation, colony formation, and cell invasion inhibition. These results showed miR-27b could regulate OS progression by targeting HOXB8.
Discussion
As a crucial gene regulator, miRNA can function as either tumor suppressor or promoter in tumor progression. 16 For example, knockdown miR-217 expression could promote OS cell proliferation and invasion by targeting SET domaincontaining Protein 8.
17 Downregulation of miR-758 was found to be correlated with large tumor size, advance clinical stage, worse distant metastasis, and poor overall survival in OS. 18 Moreover, miR-758 overexpression inhibited OS progression in vitro and in vivo via targeting high mobility group AT-hook 1 and regulating the Wnt/b-catenin pathway. 18 In addition, miR-1258 downregulation was reported to be associated with malignant clinical parameters and poor survival in patients with OS. 19 The present study investigated the biological roles of miR27b in OS. Consistent with the tumor suppressive role of miR27b in hepatocellular carcinoma, colorectal cancer, and gastric cancer, 6 -8 the present study demonstrated that miR-27b expression was significantly lower in OS cell lines compared to the normal cell line. Moreover, we found the overexpression of miR-27b inhibits OS cell proliferation, colony formation, and cell invasion in vitro when compared to the NC-miR. As miR-27b was downregulated in OS, we explored the underlying mechanism of miR-27b in OS. By TargetScan prediction, we found HOXB8 was a potential target for miR-27b as they showed complementary binding in 3 0 -UTR. We observed miR-27b mimic transfection could inhibit the relative luciferase activity of OS cells transfected with wt-HOXB8, indicating that miR-27b could bind to the 3 0 -UTR of HOXB8. Importantly, it was found miR-27b mimic introduction could reduce the expression level of HOXB8 in OS cell lines. These results confirmed the direct connection between miR-27b and HOXB8. Rescue experiments demonstrated HOXB8 overexpression could reverse the miR-27b mimic-induced OS cell growth and invasion inhibition, indicating HOXB8 was a functional target of miR-27b. It has been reported that targeting HOX gene is a potential way to control cancer progression. 20 Therefore, our work indicated that controlling miR-27b expression may be a novel method to control HOXB8 expression in human cancers, which will help to establish the role of HOXB8 in cancers. There are limitations in this article that should be noteworthy. The expression of HOXB8 in OS tissues was not investigated in this current work, which should be performed to strengthen the findings of our work. Moreover, this work focused on the in vitro effects of miR-27b-HOXB8 axis in OS; hence, further investigations are needed to determine the effect of miR-27b/HOXB8 on in vivo tumorigenesis of OS.
To conclude, our research confirmed the tumor suppressive role of miR-27b in OS. Overexpression of miR-27b inhibited OS growth and invasion by targeting HOXB8. We hypothesized that miR-27b and HOXB8 could be possible molecular targets for OS treatment.
